Hybrid approaches using mouse genetics and in vitro organoids have also allowed the development of tumorigenic mouse organoids that overexpress Sox2 and harbour deletions in the key LUSC tumour suppressor genes Trp53, Cdkn2a and Pten [78]. This evidence concerns the gene SOX2 and neoplasm.